Cytori Therapeutics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cytori Therapeutics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: SnowShredder	10/26/2005 12:28:25 PM
	Read Replies (2) of 251

Cytori Therapeutics to Present at the Rodman and Renshaw Techvest 7th Annual Healthcare Conference fwiw... ir.cytoritx.com Best of Luck, SS >>>> Cytori Therapeutics to Present at the Rodman and Renshaw Techvest 7th Annual Healthcare Conference San Diego CA, October 25, 2005 – Cytori Therapeutics, Inc. (Frankfurt: XMP) announced today that it will present and provide an audio webcast of its corporate presentation at the Rodman and Renshaw Techvest 7th Annual Healthcare Conference on Tuesday, November 8, 2005 at 4:35 P.M. Eastern Standard Time (10:35 P.M. Central European Time) from The New York Palace Hotel, New York, NY. The audio webcast may be accessed at "Events & Webcasts" in the News and Events section of the Company's website at ir.cytoritx.com. The webcast may also be accessed through the Rodman & Renshaw website at rodmanandrenshaw.com. Please click on the "Conferences" link and find details for the "Rodman & Renshaw Techvest 7th Annual Healthcare Conference." About Cytori Therapeutics Cytori Therapeutics (Frankfurt: XMP) is discovering and developing proprietary cell-based therapeutics utilizing adult stem cells derived from adipose, also known as fat tissue. The Company's preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem cells, Cytori is developing its proprietary Celution™ system to isolate and concentrate a patient's own stem cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients. Contacts: Tom Baker Media/U.S. Investors Tel. 001-858 232 7234 tbaker@cytoritx.com Stefanie Bacher International Investors Tel. 001-858 232 7234 sbacher@cytoritx.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next